Access to the BOSS™ technology through eye care professionals could provide the following patient benefits:
>> Young children could benefit from screening of refractive disorders and the prevention of abnormal vision progression (e.g., keratoconus and high myopia);
>> Adults in their 20s to 40s could benefit from enhanced refractive surgical outcomes based on individualized biomechanical analysis;
>> The Middle-aged to elderly population could benefit in a variety of ophthalmic surgical procedures in which outcome and healing control are critical.
“I see BOSS™ becoming a standard of care to further optimize laser vision correction, astigmatism correction, and corneal cross-linking as well as to screen patients at risk for developing keratoconus, ectasia, and potentially even high myopia and glaucoma.” Richard L. Lindstrom, MD